DEA does not publish any proposed rescheduling rule for psilocybin or MDMA within 30 days.

Predicted 2026-07-20 · Resolves 2026-08-19 · regulatory · USA

85%

ORACLE CONFIDENCE

⏳ Pending

Every outcome is scored publicly in the ledger.

The DEA (Drug Enforcement Administration, the US agency that controls which drugs are legal) is very unlikely to publish any formal paperwork moving psilocybin or MDMA off the most restricted drug list in the next 30 days. This matters because until that paperwork appears, both substances stay fully illegal at the federal level — no matter what individual states do.

Resolution rule: YES if, as of 2026-08-19, no proposed OR final rule rescheduling psilocybin or MDMA out of Schedule I appears in the Federal Register (federalregister.gov, DEA agency filings) between 2026-07-20 and 2026-08-19. NO if any such rule is published in that window.

Administrative rescheduling requires HHS scheduling recommendation and DEA review; no such action is queued near-term. The enforcement posture holds in the immediate window.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →